Sumitomo Mitsui Trust Group’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.6M Sell
795,551
-22,171
-3% -$811K 0.02% 569
2026
Q2
$32.3M Buy
817,722
+791,274
+2,992% +$31.9M 0.02% 556
2026
Q1
$1.18M Buy
+26,448
New +$1.17M ﹤0.01% 844

Other funds holding MDLN

Sumitomo Mitsui Trust Group's MDLN Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group reduced its Medline Inc (MDLN) stake by 2.7% in Q3 2026, selling an estimated $811K and leaving 795,551 shares worth $27.6M. The position accounts for 0.02% of the portfolio, ranked #569.

Sumitomo Mitsui Trust Group first reported a position in MDLN in Q1 2026 and has held it in 3 quarters since. The position peaked at $32.3M in Q2 2026. 102 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Sumitomo Mitsui Trust Group held 795,551 shares of Medline Inc worth $27.6M as of Q3 2026.
  • Sumitomo Mitsui Trust Group sold 22,171 Medline Inc shares in Q3 2026, an estimated $811K.
  • Medline Inc made up 0.02% of Sumitomo Mitsui Trust Group's portfolio in Q3 2026, its #569 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Medline Inc in Q1 2026 and has held it in 3 quarters since.
  • Sumitomo Mitsui Trust Group's Medline Inc position peaked at $32.3M in Q2 2026.
  • 102 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.